Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-01-28
Buyer: Sykehusinnkjøp HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 1700000 NOK
Award criteria: Lowest price

Technical requirements: Additional contract with Mylan Healthcare Norge AS after tender competition LIS 1901 special pharmaceutical preparations for N07AA51 Robinul neostigmin inj.
Sykehusinnkjøp HF, Divisjon legemidler (LIS) is collecting tenders for medicines that are used by the Health Trusts. LIS has previously announced and held an open tender competition for special pharmaceutical preparations (“LIS 1901 Special Pharmaceutical Preparations” — LIS 1901). The competition included the active ingredients in accordance with the tender documentation's annex 3 Active Ingredients List.
After the contracts were signed we received tenders for robinul neostigmin (ATC-code N07AA51), which there were no tenderers for in the tender competition.
Due to this, LIS intends to enter into contracts between the regional health trusts (the Contracting Authorities) and Mylan Healthcare Norge AS (the Supplier) as an additional contract to LIS 1901, i.e. the scope and length of the contract will follow the mentioned procurement (including access to extensions and notice), without a new competition being held for this ingredient. The health companies that are under the regional health trusts have an option to join the contracts.
LIS has examined the market situation and is of the opinion that it is not possible to have a new competition, or that another supplier than Mylan Healthcare Norge AS can deliver the product in this contract period. In addition, the situation that has occurred is not the Contracting Authority's fault, nor something that the Contracting Authority could foresee. LIS therefore believes that there are grounds to make the procurement without a competition. See the public procurement regulations, § 21-5, cf. § 21-2, cf. § 13-4 letter b) No. 2.
LIS requests that those who have objections to this submit feedback before the waiting period expires on 6.2.2019. If no objections are received, a contract will be signed after the waiting period has expired.
Sykehusinnkjøp HF, Divisjon legemidler (LIS) is collecting tenders for medicines that are used by the Health Trusts. LIS has previously announced and held an open tender contest for special pharmaceutical preparations (“LIS 1901 Special Pharmaceutical Preparations”, LIS 1901). The contest was for the active ingredients that were in accordance with the tender documentation, annex 3 Active Ingredients List.
After the contracts were signed we received tenders for robinul neostigmin (ATC-code N07AA51), which there were no tenderers for in the tender competition.
Due to this, LIS intends to enter into contracts between the regional health trusts (the Contracting Authorities) and Mylan Healthcare Norge AS (the Supplier) as an additional contract to LIS 1901, i.e. the scope and length of the contract will follow the mentioned procurement (including access to extensions and notice), without a new competition being held for this ingredient. The health companies that are under the regional health trusts have an option to join the contracts.


Winner: Mylan Healthcare Norge AS
Award value: 1700000